EMMa Electronic Monitoring Management
Detector And Alarm, Arrhythmia. 510(k) K153477, from Vitasystems GmbH (Mannheim, DE). Product code DSI, class 2.
As of Nov 17, 2026, K153477 is an FDA 510(k) held by Vitasystems GmbH, substantially equivalent on May 25, 2016 after 175 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: May 25, 2016
- Review time: 175 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe EMMa system is intended for diagnostic evaluation of patients who experience transient symptoms or asymptomatic events that may suggest non-lethal cardiac arrhythmia to support and possibly improve an ongoing treatment by the patient’s physician.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Telesentry, Model TS01K092947 · Scottcare Corporation · Feb 26, 2010
Other DSI Clearances
The newest 510(k)s for the same product code; their median review was 248 days; see every DSI device- BodyGuardian Remote Monitoring System (BGRMS v3.0)K243349 · Boston Scientific Cardiac Diagnostic Technologies, Inc. · Jan 23, 2026
- MoMe ARC® Wireless Ambulatory ECG Monitoring and Detection System (32000)K250356 · Infobionic, Inc. · Jul 29, 2025
- Zio AT® device (A100A1001)K240177 · iRhythm Technologies, Inc. · Oct 30, 2024
- MoMe® ARC Wireless Ambulatory ECG Monitoring and Detection SystemK230265 · Infobionic, Inc. · Oct 6, 2023
- SmartCardia 7L PlatformK231276 · Smartcardia SA · Aug 30, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 2, 2015
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files